Optometrist Wes Molenaar, OD, sees the USA as part of Harley-Davidson ABCs of Touring competition.

Meibomian gland dysfunction never went away, but current interest by researchers has put MGD on the front burner.

Optometrists need to understand RA and how to manage its ophthalmic impact on patients.

The co-managing optometrist is the go-to person when patients elect ATIOLs.

The most challenging part of offering premium intraocular lenses (IOLs) at your practice happens long before a surgeon enters the operating room. That challenge is providing the IOL that best meets the patient's vision needs and lifestyle.

Understanding the whys and wherefores enables techs and doctors to work together effectively.

Daily disposable contact lenses provide a clean, deposit-free, sterile lens in a saline-based solution on a daily basis, so that each new lens is comfortable, safe, and convenient.

The prevalence of autism spectrum disorder (ASD) means that most optometrists can expect to provide care to these patients-yet many ODs feel unprepared to do so.

When you co-manage a patient for a surgical procedure, be prepared for some common post-op doctor-patient dialogues.

Simple, but effective, tips can help doctors use online feedback to build a practice.

Answering the question: “Which is better, one or two?" can lead to some confusion on the patient’s part.

Optovue has received FDA 510(k) clearance for its iFusion system, which combines iVue SD-OCT with the iCam color fundus camera on a single delivery platform.

Corporate-affiliated doctors partner with EyeCare Pro

Regeneron Pharmaceuticals and Bayer HealthCare have announced that in the Phase III trials of Eylea (aflibercept) injection for treating DME, Eylea 2 mg achieved significantly greater improvement in BCVA from baseline compared with laser photocoagulation at 52 weeks.

August is National Eye Exam Month, the perfect time to recommend that your patients schedule a comprehensive eye exam.

An agreement establishing a new Partnership Endowment was signed recently at the board of directors’ meeting of the Partnership Foundation for Optometric Education and the Association of Schools and Colleges of Optometry.

Orthokeratology has re-emerged as a treatment for myopia, however, its high price tag may hinder its adoption in the corrective vision market.

ORBIS has brought back the Flying Eye Hospital (FEH) to Panama City for a comprehensive skills exchange program aimed at advanced subspecialty training and raising awareness of eye care related conditions in Panama.

Canada's Valeant Pharmaceuticals, new owner of Bausch + Lomb (B+L), the company will reduce its workforce by as much as 15% worldwide, move B+L's headquarters, and combine B+L's three business units into one operation.